FDA warning letter
Issue date
27 Sept 2022
Issuing office
Center for Drug Evaluation and Research | CDER
Posted date
1 Nov 2022
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
FDA warning letter
Issue date
10 Sept 2019
Issuing office
Center for Drug Evaluation and Research
Posted date
1 Oct 2019
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs